John Sharman - Mar 25, 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC (UBI)

Role
Chief Executive Officer
Signature
/s/ John Sharman
Stock symbol
UBI
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
4
Date filed
5/3/2024, 06:18 AM
Previous filing
Jan 3, 2023
Next filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Gift $0 +1M +362.03% $0.00 1.28M Mar 25, 2024 By wife F1
transaction UBI Common Stock Gift $0 -1M -92.59% $0.00 80K Mar 25, 2024 Direct F1
holding UBI Common Stock 365K Mar 25, 2024 By superannuation fund F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UBI Performance Rights 2.5M Mar 25, 2024 Common Stock 2.5M Direct F4
holding UBI Performance Rights 1.25M Mar 25, 2024 Common Stock 1.25M Direct F5
holding UBI Stock Option (Right to Buy) 2.36M Mar 25, 2024 Common Stock 2.36M $0.25 Direct F2, F6
holding UBI Stock Option (Right to Buy) 1.36M Mar 25, 2024 Common Stock 1.36M $0.30 Direct F2, F6
holding UBI Stock Option (Right to Buy) 1M Mar 25, 2024 Common Stock 1M $0.30 By superannuation fund F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a gift of securities by the reporting person to his wife, who shares the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his wife except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 The reporting person disclaims beneficial ownership of the shares held by his superannuation except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his superannuation funds shares for purposes of Section 16 or for any other purpose.
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.
F6 These options are fully vested and became exercisable after September 24, 2020.